Drug Trials Snapshots | FDA,,,,
Brand Name (Drug Trials Snapshot),Drug Name,Original Date of FDA Approval,FDA Approved Use on Original Approval Date*,Brand Name (Prescribing Information)
NEMLUVIO,nemolizumab-ilto,"August 12, 2024",To treat prurigo nodularis,Nemluvio
YORVIPATH,palopegteriparatide,"August 9, 2024",To treat hypoparathyroidism,Yorvipath
IZERVAY,avacincaptad pegol intravitreal solution,"August 4, 2023",To treat geographic atrophy secondary to age-related macular degeneration,Izervay
PIASKY,crovalimab-akkz,"June 20, 2024",Treatment of paroxysmal nocturnal hemoglobinuria,Piasky
XOLREMDI,mavorixafor,"April 26, 2024","For the treatment of adults and adolescents over the age of 12 years with WHIM (Warts, Hypogammaglobulinemia, Infection, and Myelokathexis) syndrome",Xolremdi
ZEVTERA,ceftobiprole medocaril sodium for injection,"April 3, 2024","Treatment of certain bloodstream infections, bacterial skin and associated tissue infections, and community-acquired bacterial pneumonia",Zevtera
VOYDEYA,danicopan,"March 29, 2024",To treat extravascular hemolysis with paroxysmal nocturnal hemoglobinuria,Voydeya
WINREVAIR,sotatercept-csrk,"March 26, 2024",For the treatment of adults with pulmonary arterial hypertension,Winrevair
DUVYZAT,givinostat,"March 21, 2024",Treatment of Duchenne muscular dystrophy in individuals aged 6 years and older,Duvyzat
TEVIMBRA,tislelizumab-jsgr,"March 14, 2024",To treat unresectable or metastatic esophageal squamous cell carcinoma,Tevimbra
LETYBO,letibotulinumtoxinA,"February 29, 2024",To temporarily improve the appearance of moderate-to-severe glabellar lines,Letybo
EXBLIFEP,cefepime and enmetazobactam,"February 22, 2024",For the treatment of patients 18 years and older with complicated urinary tract infections (cUTI),Exblifep
ZELSUVMI,berdazimer,"January 5, 2024",Treatment of molluscum contagiosum,Zelsuvmi 
WAINUA,eplontersen,"December 21, 2023",To treat polyneuropathy of hereditary transthyretin-mediated amyloidosis,Wainua
FILSUVEZ,birch triterpenes,"December 18, 2023",To treat wounds associated with dystrophic and junctional epidermolysis bullosa,Filsuvez
XENOVIEW,xenon Xe 129 hyperpolarized,"December 8, 2023",Evaluation of lung ventilation in adults and pediatric patients,Xenoview
VTAMA,tapinarof,"December 7, 2023",Treatment of plaque psoriasis,Vtama
OGSIVEO,nirogacestat,"November 27, 2023",To treat adults with progressing desmoid tumors who require systemic treatment,Ogsiveo
OHTUVAYRE,ensifentrine,"June 26, 2024",For the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adult patients.,Ohtuvayre
OJEMDA,tovorafenib,"April 23, 2024",To treat certain types of brain tumors (cancers) called gliomas in patients 6 months and older,Ojemda
OJJAARA,momelotinib,"September 15, 2023",to treat a rare type of bone marrow disorder called myelofibrosis (MF) in adults with anemia,Ojjaara
RYZNEUTA,efbemalenograstim alfa-vuxw,"November 11, 2023",To treat neutropenia,Ryzneuta
TRUQAP,capivasertib,"November 16, 2023",To treat breast cancer that meets certain disease criteria,Truqap
AUGTYRO,repotrectinib,"November 15, 2023",To treat ROS1-positive non-small cell lung cancer,Augtyro
DEFENCATH,"taurolidine, heparin","November 15, 2023",To reduce the incidence of catheter-related bloodstream infections in adults with kidney failure receiving chronic hemodialysis through a central venous catheter.,Defencath
FRUZAQLA,fruquintinib,"November 8, 2023","To treat refractory, metastatic colorectal cancer",Fruzaqla
AGAMREE,vamorolone,"October 26, 2023",Treatment of Duchenne muscular dystrophy,Agamree
BIMZELX,bimekizumab-bkzx,"October 17, 2023",Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.,Bimzelx
ZILBRYSQ,zilucoplan,"October 17, 2023",To treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor (AChR) antibody positive,Zilbrysq
VELSIPITY,etrasimod,"October 12, 2023",To treat moderately to severely active ulcerative colitis in adults,Velsipity
RIVFLOZA,nedosiran,"September 29, 2023",To lower urinary oxalate levels in patients 9 years and older with primary hyperoxaluria type 1 and relatively preserved kidney function,Rivfloza
POMBILITI,cipaglucosidase alfa-atga,"September 28, 2023",the treatment of adult patients with late-onset Pompe disease (LOPD),Pombiliti Opfolda
APHEXDA,motixafortide,"Sepetember 8, 2023",To mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma,Aphexda
XENPOZYME,olipudase alfa-rpcp,"August 31, 2023",To treat Acid Sphingomyelinase Deficiency,Xenpozyme
VEOPOZ,pozelimab-bbfg,"August18, 2023","To treat patients 1 year old and older with CD55-deficient protein-losing enteropathy (PLE), also known as CHAPLE disease",Veopoz
SOHONOS,palovarotene,"August 16, 2023",To reduce the volume of new heterotopic ossification in adults and pediatric patients (aged 8 years and older for females and 10 years and older for males) with fibrodysplasia ossificans progressiva,Sohonos
ELREXFIO,elranatamab-bcmm,"August 14, 2023",To treat adults with relapsed or refractory multiple myeloma who have received at least four prior lines of therapy,Elrexfio
ZURZUVAE,zuranolone,"August 4, 2023",To treat postpartum depression,Zurzuvae
VANFLYTA,quizartinib,"July 20, 2023",To use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria,Vanflyta
BEYFORTUS,nirsevimab,"July 17, 2023",Prevention of respiratory syncytial virus (RSV) lower respiratory tract disease.,Beyfortus
NGENLA,somatrogon-ghla,"June 27, 2023",Treatment of growth failure due to inadequate secretion of endogenous growth hormone,Ngenla
RYSTIGGO,rozanolixizumab-noli,"June 26, 2023",To treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor- or anti-muscle-specific tyrosine kinase antibody-positive,Rystiggo
RYTELO,imetelsta,"June 6, 2024",to treat a condition called low- to intermediate-1 risk myelodysplastic syndromes (MDS) in adults with anemia,Rytelo
COLUMVI,glofitamab-gxbm,"June 15, 2023","Treatment of diffuse large B-cell lymphoma, not otherwise specified, or large B-cell lymphoma arising from follicular lymphoma after two or more lines of systemic therapy",Columvi
INPEFA,sotagliflozin,"May 26, 2023",Treatment of heart failure,Inpefa
PAXLOVID,"nirmatrelvir, ritonavir","May 25, 2023",To treat mild-to-moderate COVID-19 in adults at high risk for progression to severe COVID-19,Paxlovid
POSLUMA,flotufolastat F 18,"May 25, 2023",To detect specific cancer lesions in males with prostate cancer,Posluma
XACDURO,sulbactam for injection; durlobactam for injection,"May 23, 2023",Treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible isolates of Acinetobacter baumannii-calcoaceticus complex,Xacduro
VEOZAH,fezolinetant,"May 12, 2023",To treat moderate to severe hot flashes caused by menopause,Veozah
QALSODY,tofersen,"April 25, 2023",Treatment of amyotrophic lateral sclerosis in adults who have a SOD1 gene mutation,Qalsody
EPKINLY,epcoritamab-bysp,"May 19, 2023",To treat relapsed or refractory diffuse large B-cell lymphoma (not otherwise specified) and high-grade B-cell lymphoma after two or more lines of systemic therapy,Epkinly
JOENJA,leniolisib,"March 24, 2023",Treatment of activated phosphoinositide 3-kinase delta syndrome.,Joenja
ZTALMY,ganaxolone,"March 18, 2023",To treat seizures in cyclin-dependent kinase-like 5 deficiency disorder,Ztalmy
DAYBUE,trofinetide,"March 12, 2023",To treat Rett syndrome.,Daybue
ZAVZPRET,zavegepant,"March 9, 2023",To treat migraine,Zavzpret
SKYCLARYS,omaveloxolone,"February 28, 2023",To treat Friedrich’s ataxia,Skyclarys
FILSPARI,sparsentan,"February 17, 2023",To reduce proteinuria in adults with primary immunoglobulin A nephropathy at risk of rapid disease progression,Filspari
JESDUVROQ,daprodustat,"February 1, 2023",Treatment of anemia caused by chronic kidney disease for adults on dialysis for at least four months.,Jesduvroq
JAYPIRCA,pirtobrutinib,"January 27, 2023","To treat relapsed or refractory mantle cell lymphoma in adults who have had at least two lines of systemic therapy, including a BTK inhibitor",Jaypirca
ORSERDU,elacestrant,"January 27, 2023","To treat estrogen receptor-positive, human epidermal growth factor receptor 2-negative, ESR1-mutated, advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.",Orserdu
BRENZAVVY ,bexagliflozin,"January 20, 2023",To improve glycemic control in adults with type 2 diabetes mellitus as an adjunct to diet and exercise,Brenzavvy
LEQEMBI,lecanemab-irmb,"January 6, 2023",Treatment of Alzheimer’s disease,Leqembi
LEQSELVI,deuruxolitinib,"July 25, 2024",Indicated for the treatment of adults with severe alopecia areata (AA).,Leqselvi
BRIUMVI,ublituximab-xiiy,"December 28, 2022",To treat relapsing forms of multiple sclerosis,Briumvi
NEXOBRID,anacaulase-bcdb,"December 28, 2022",To remove charred tissue in adults with deep second degree and/or third degree burns from heat sources,Nexobrid
LUNSUMIO,mosunetuzumab-axgb,"December 22, 2022","To treat adults with relapsed or refractory follicular lymphoma, a type of non-Hodgkin lymphoma",Lunsumio
SUNLENCA,lenacapavir,"December 22, 2022","To treat adults with HIV whose HIV infections cannot be successfully treated with other available treatments due to resistance, intolerance, or safety considerations",Sunlenca
KRAZATI,adagrasib,"December 12, 2022",Prescription medicine used to treat adult patients with non-small cell lung cancer,Krazati
REZDIFFRA,resmetirom,"March 14, 2024","To treat adults with nonalcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver.",Rezdiffra
REZLIDHIA,olutasidenib,"December 1, 2022",Treatment of adults with relapsed or refractory acute myeloid leukemia with a susceptible isocitrate dehydrogenase-1 (IDH1) mutation,Rezlidhia
ELAHERE,mirvetuximab soravtansine-gynx,"November 14, 2022",To treat patients with recurrent ovarian cancer that is resistant to platinum therapy,Elahere
ELFABRIO,pegunigalsidase alfa-iwx,"May 9, 2023",An enzyme replacement therapy that is used for the treatment of Fabry disease in adult patients.,Elfabrio
TECVAYLI ,teclistamab-cqyv,"October 25, 2022",To treat relapsed or refractory multiple myeloma among adults who have received at least four specific lines of therapy,Tecvayli
IMJUDO,tremelimimab-actl,"October 21, 2022",To treat unresectable hepatocellular carcinoma,Imjudo
LYTGOBI,futibatinib,"September 30, 2022",To treat intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements,Lytgobi
RELYVRIO,sodium phenylbutyrate and taurursodiol,"September 29, 2022",To treat amyotrophic lateral sclerosis (ALS),Relyvrio
OMLONTI,oomidenepag isopropyl,"September 22, 2022",Reduces elevated intraocular pressure in patients with open‑angle glaucoma or ocular hypertension,Omlonti
ELUCIREM,gadopiclenol,"September 21, 2022","To detect and visualize lesions, together with MRI, with abnormal vascularity in the central nervous system and the body",Elucirem
TERLIVAZ,terlipressin,"September 14, 2022",Treatment to improve kidney function in adults with hepatorenal syndrome (HRS) with rapid reduction in kidney function,Terlivaz
ROLVEDON,eflapegrastim,"September 9, 2022",To decrease the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with clinically significant incidence of febrile neutropenia,Rolvedon
SOTYKTU,deucravacitinib,"September 9, 2022",To treat moderate-to-severe plaque psoriasis,Sotyktu
DAXXIFY,daxibotulinumtoxin A,"September 7, 2022",To treat moderate-to-severe glabellar lines associated with corrugator and/or procerus muscle activity.,Daxxify
SPEVIGO,spesolimab-sbzo,"September 1, 2022",To treat generalized pustular psoriasis flares,Spevigo
AMVUTTRA,vutrisiran,"June 13, 2022",To treat polyneuropathy of hereditary transthyretin-mediated amyloidosis,Amvuttra
MOUNJARO,tirzepatide,"May 13, 2022","To improve blood sugar control in diabetes, in addition to diet and exercise",Mounjaro
VOQUEZNA,"vonoprazan fumarate, amoxicillin","May 3, 2022",Treatment of Helicobacter pylori infection,Voquezna
CAMZYOS,mavacamten,"April 28, 2022",To treat certain classes of obstructive hypertrophic cardiomyopathy,Camzyos
VIVJOA,oteseconazole,"April 26, 2022",To reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are not of reproductive potential,Vivjoa
PLUVICTO,lutetium Lu 177 vipivotide tetraxetan,"March 23, 2022",To treat prostate-specific membrane antigen-positive metastatic castration-resistant prostate cancer following other therapies,Pluvicto
OPDUALAG,nivolumab and relatlimab-rmbw,"March 18, 2022",Treatment of adults and pediatric patients 12 years of age or older with a type of skin cancer called melanoma that cannot be removed by surgery (unresectable) or has spread to other parts of the body (metastatic).,Opdualag
PYRUKYND,mitapivat,"February 17, 2022",Treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency,Pyrukynd
ENJAYMO,sutimlimab-jome,"February 4, 2022",To decrease the need for red blood cell transfusion due to hemolysis in cold agglutinin disease,Enjaymo
VABYSMO,faricimab-svoa,"January 28, 2022",To treat neovascular (wet) aged-related macular degeneration and diabetic macular edema,Vabysmo
KIMMTRAK,tebentafusp,"January 25, 2022",To treat unresectable or metastatic uveal melanoma,Kimmtrak
CIBINQO,abrocitinib,"January 14, 2022","Treatment of adults with refractory, moderate-to-severe atopic dermatitis",Cibinqo
QUVIVIQ,daridorexant,"January 7, 2022","Treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.",Quvivq
ADBRY,tralokinumab-ldrm,"December 27, 2021",To treat moderate-to-severe atopic dermatitis,Adbry
LEQVIO,inclisiran,"December 22, 2021",To treat heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease as an add-on therapy,Leqvio
TEZSPIRE,Tezepelumab,"December 17, 2021",To treat severe asthma as an add-on maintenance therapy,Tezspire
VYVGART,Vyvgart alfa-fcab,"December 17, 2021",For the treatment of generalized myasthenia gravis (gMG) in adult patients,Vyvgart
LIVTENCITY,maribavir,"November 23, 2021",To treat post-transplant cytomegalovirus (CMV) infection/disease that does not respond (with or without genetic mutations that cause resistance) to available antiviral treatment for CMV,Livtencity
VOXZOGO,vosoritide,"November 20, 2021",To improve growth in children five years of age and older with achondroplasia and open epiphyses,Voxzogo
CYTALUX ,pafolacianine,"November 19, 2021",To help identify ovarian cancer lesions,Cytalux
BESREMi ,ropeginterferon alfa-2b-njft,"November 12, 2021","To treat polycythemia vera, a blood disease that causes the overproduction of red blood cells",Besremi
SCEMBLIX,asciminib,"October 29, 2021",To treat Philadelphia chromosome-positive chronic myeloid leukemia with disease that meets certain criteria,Scemblix
TAVNEOS,avacopan,"October 7, 2021",Treatment of adults with severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis,Tavneos
LIVDELZI,seladelpar,"August 14, 2024",To treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have an inadequate response to UDCA or as monotherapy in patients unable to tolerate UDCA.,Livdelzi
LIVMARLI,maralixibat chloride,"September 29, 2021",To treat cholestatic pruritus associated with Alagille syndrome,Livmarli
QULIPTA,atogepant,"September 28, 2021",To prevent episodic migraines,Qulipta
TIVDAK,tisotumab vedotin-tftv,"September 20, 2021",To treat recurrent or metastatic cervical cancer with disease progression on or after chemotherapy,Tivdak
EXKIVITY,mobocertinib,"September 15, 2021",Treatment of adult patients with a type of lung cancer (non-small cell lung cancer or NSCLC),Exkivity
SKYTROFA,lonapegsomatropin-tcgd,"August 25, 2021",treatment of children 1 year and older who weigh at least 11.5 kilograms and are not growing because they have growth hormone deficiency (GHD),Skytrofa
KORSUVA,Difelikefalin,"August 23, 2021",To treat moderate-to-severe pruritus associated with chronic kidney disease in certain populations,Korsuva
WELIREG,belzutifan,"August 13, 2021",Treatment of von Hippel-Lindau disease under certain conditions,Welireg
NEXVIAZYME,avalglucosidase alfa-ngpt,"August 6, 2021",Treatment of patients 1 year of age and older with late-onset Pompe disease (LOPD),Nexviazyme
SAPHNELO,anifrolumab-fnia,"July 30, 2021",To treat moderate-to severe systemic lupus erythematousus along with standard therapy,Saphnelo
BYLVAY,odevixibat,"July 20, 2021",Treatment of pruritus.,Bylvay
FEXINIDAZOLE, ,"July 16, 2021",To treat human African trypanosomiasis caused by the parasite Trypanosoma brucei gambiense,Fexinidazole
REZUROCK,belumosudil,"July 16, 2021",To treat chronic graft-versus-host disease after failure of at least two prior lines of systemic therapy,Rezurock
REZZAYO,rezafungin for injection,"March 22, 2023",To treat candidemia and invasive candidiasis,Rezzayo
KERENDIA,finerenone,"July 9, 2021",Treatment of adults with chronic kidney disease (CKD) associated with type 2 diabetes (T2D),Kerendia
ADUHELM,Aducanumab,"July 7, 2021",To treat Alzheimer’s disease,Aduhelm
RYLAZE,asparaginase erwinia chrysanthemi (recombinant)-rywn,"June 30, 2021","To treat acute lymphoblastic leukemia and lymphoblastic lymphoma in patients who are allergic to E. coli-derived asparaginase products, as a component of a chemotherapy regimen",Rylaze
BREXAFEMME,ibrexafungerp,"June 1, 2021",To treat vulvovaginal candidiasis,Brexafemme
LUMAKRAS,Sotorasib,"May 28, 2021",For the treatment of adult patients with non-small cell lung cancer (NSCLC) that is locally advanced or has spread to other parts of the body (metastatic),Lumakras
LYBALVI,olanzapine and samidorphan,"May 28, 2021",For the treatment of schizophrenia and certain aspects of bipolar I disorder,Lybalvi
TRUSELTIQ,infigratinib,"May 28, 2021",To treat cholangiocarcinoma whose disease meets certain criteria,Truseltiq
PYLARIFY,piflufolastat F 18,"May 26, 2021",To identify prostate-specific membrane antigen-positive lesions in prostate cancer,Pylarify
RYBREVANT,amivantamab-vmjw,"May 21, 2021",Treatment of adults with non-small cell lung cancer (NSCLC).,Rybrevant
EMPAVELI,pegcetacoplan,"May 14, 2021",Treatment of adults with a disease called paroxysmal nocturnal hemoglobinuria (PNH),Empaveli
AZSTARYS,serdexmethylphenidate and dexmethylphenidate,"May 7, 2021",To treat attention deficit hyperactivity disorder,Azstarys
ZYNLONTA,loncastuximab tesirine-lpyl,"April 23, 2021",To treat certain types of relapsed or refractory large B-cell lymphoma,Zynlonta
JEMPERLI,dostarlimab-glxy,"April 22, 2021",Treatment of adult females with uterine cancer (endometrial cancer).,Jemperli
NEXTSTELLIS,estetrol and drospirenone,"April 15, 2021",To prevent pregnancy,Nextstellis
QELBREE,viloxazine,"April 2, 2021",Treatment of attention deficit hyperactivity disorder (ADHD) in children 6 to 17 years of age,Qelbree
ZEGALOGUE,dasiglucagon,"March 22, 2021",To treat severe hypoglycemia,Zegalogue
PONVORY,ponesimod,"March 18, 2021",Treatment of relapsing forms of multiple sclerosis (MS),Ponvory
FOTIVDA,tivozanib,"March 10, 2021",Treatment of adult patients with advance kidney cancer (advanced renal cell carcinoma or RCC) that has been treated with 2 or more prior medicines and has come back or did not respond to treatment.,Fotivda
NULIBRY,fosdenopterin,"February 26, 2021",To reduce the risk of death in patients with molybdenum cofactor deficiency (MoCD) Type A.,Nulibry
PEPAXTO,melphalan flufenamide,"February 26, 2021",Treatment of adults with multiple myeloma,Pepaxto
AMONDYS 45,casimersen,"February 25, 2021",Treatment of a particular type of Duchenne muscular dystrophy (DMD). It is to be used only in patients who have a specific mutation of the dystrophin gene.,Amondys 45
COSELA,trilaciclib,"February 12, 2021",Decrease the rate of bone marrow suppression (myelosuppression) resulting from chemotherapy in adult patients when given prior to certain chemotherapy drugs (containing platinum/etoposide or topotecan) for a type of lung cancer (extensive stage-small cell lung cancer) that is widespread.,Cosela
EVKEEZA,evinacumab-dgnb,"February 11, 2021",Used along with other low-density lipoprotein (LDL) lowering medicines in people older than 12 years of age with a type of high cholesterol called homozygous familial hypercholesterolemia (HoFH).,Evkeeza
UKONIQ,umbralisib,"February 5, 2021",Treatment of adult patients with follicular lymphoma ,Ukoniq
UKONIQ,umbralisib,"February 5, 2021",Treatment of adult patients with marginal zone lymphoma (MZL) ,Ukoniq
TEPMETKO,tepotinib,"February 3, 2021",Treatment of a type of non-small cell lung cancer (NSCLC) which has a specific set of gene alterations and has spread to other parts of the body (metastatic).,Tepmetko
LUPKYNIS,voclosporin,"January 22, 2021",Treatment of lupus nephritis,Lupkynis
CABENUVA,cabotegravir and rilpivirine,"January 20, 2021",Treatment of HIV-1 infection.,Cabenuva
VERQUVO,vericiguat,"January 19, 2021",Treatment of chronic heart failure,Verquvo
GEMTESA,vibegron,"December 23, 2020",Treatment of symptoms of overactive bladder,Gemtesa
EBANGA,ansuvimab-zykl,"December 21, 2020",Treatment of Zaire ebolavirus infection,Ebanga
ORGOVYX,relugolix,"December 18, 2020",Treatment of advanced prostate cancer,Orgovyx
MARGENZA,margetuximab-cmkb,"December 16, 2020 ",Treatment of metastatic breast cancer,Margenza
KLISYRI,tirbanibulin,"December 14, 2020",Treatment of actinic keratosis,Klisyri
ORLADEYO,berotralstat,"December 3, 2020",Prevention of attacks of hereditary angioedema (HAE) in patients 12 years and older.,Orladeyo
Ga 68 PSMA-11, ,"December 1, 2020",Detection of specific cancer lesions in men with prostate cancer,Ga 68 PSMA-11
DANYELZA,naxitamab-gqgk,"November 25, 2020",Treatment of high-risk neuroblastoma,Danyelza
ZOKINVY,lonafarnib,"November 20, 2020",To treat rare conditions related to premature aging,Zokinvy
VEKLURY,remdesivir,"October 22, 2020",​Treatment of COVID-19,Veklury
INMAZEB,"atoltivimab, maftivimab, and odesivimab-ebgn","October 14, 2020",Treatment of Zaire ebolavirus (Ebola virus) infection,Inmazeb
GAVRETO,pralsetinib,"September 4, 2020",Treatment of non-small cell lung cancer,Gavreto
DETECTNET,copper Cu 64 dotatate,"September 3, 2020",Detection of tumors called somatostatin receptor positive neuro-endocrine tumors (NETs)., 
SOFDRA,sofpironium bromide,"June 18, 2024",An anticholinergic antiperspirant approved for primary axillary hyperhidrosis in adult and pediatric patients 9 years of age and older.,Sofdra
SOGROYA,somapacitan-beco,"August 28, 2020",Replacement of growth hormone in adults with growth hormone deficiency (GHD).,Sogroya
WINLEVI,clascoterone,"August 26, 2020",For the treatment of acne vulgaris,Winlevi
ENSPRYNG,satralizumab-mwge,"August 14, 2020",Treatment ofnneuromyelitis optica spectrum disorder (NMOSD),Enspryng
VILTEPSO,viltolarsen,"August 12, 2020",For the treatment of a particular type of Duchenne muscular dystrophy (DMD).,Viltepso
EVRYSDI,risdiplam,"August 7, 2020 ",​For the treatment of spinal muscular atrophy (SMA),Evrysdi 
OLINVYK,oliceridine,"August 7, 2020",For the treatment of acute pain,Olinvyk
LAMPIT,nifurtimox,"August 6, 2020",Treatment of Chagas disease,Lampit
LAMZEDE,velmanase alfa-tycv,"February 16, 2023",To treat non-central nervous system manifestations of alpha-mannosidosis,Lamzede
BLENREP,belantamab mafodotin-blmf,"August 5, 2020",Treatment of multiple myeloma.  ,Blenrep
MONJUVI,tafasitamab-cxix,"July 31, 2020",For the treatment of diffuse large B-cell lymphoma (DLBCL),Monjuvi
XEGLYZE,abametapir,"July 24, 2020",Treatment of head lice,Xeglyze
INQOVI,decitabine and cedazuridine,"July 7, 2020",Treatment of adults with myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia.,Inqovi
BYFAVO,remimazolam,"July 2, 2020",Treatment of starting and maintaining sedation in adults undergoing short (less than 30 minutes) procedures.,Byfavo
RUKOBIA,fostemsavir,"July 2, 2020",Treatment of HIV infection in patients with limited treatment options.,Rukobia
DOJOLVI,triheptanoin,"June 30, 2020",Source of calories and fatty acids for patients with long-chain fatty acid oxidation disorders,Dojolvi
ZEPZELCA,lurbinectedin,"June 15, 2020",Treatment of small cell lung cancer,Zepzelca
UPLIZNA,inebilizumab-cdon,"June 11, 2020",For the treatment of neuromyelitis optica spectrum disorder (NMOSD),Uplizna
ARTESUNATE, ,"May 26, 2020",Treatment on severe malaria,Artesunate
CERIANNA,fluoroestradiol F 18,"May 20, 2020",For the detection of estrogen receptor (ER)-positive lesions in patients with recurrent or metastatic breast cancer.,Cerianna
QINLOCK,ripretinib,"May 15, 2020",Treatment of gastrointestinal stromal tumors.,Qinlock
RETEVMO,selpercatinib,"May 8, 2020",Treatment of certain cancers caused by abnormal RET (rearranged during transfection) genes,Retevmo
TABRECTA,capmatinib,"May 6, 2020",Treatment of non-small cell lung cancer (NSCLC),Tabrecta
TRODELVY,sacituzumab govitecan-hziy,"April 22, 2020 ",Treatment of breast cancer,Trodelvy
PEMAZYRE,pemigatinib,"April 17, 2020",Treatment of adults with metastatic bile duct cancer (cholangiocarcinoma),Pemazyre
TUKYSA,tucatinib,"April 17, 2020",Treatment of breast cancer,Tukysa
KOSELUGO,selumetinib,"April 10,2020",For the treatment of plexiform neurofibroma,Koselugo
TAUVID,flortaucipir F 18,"March 28, 2020",To visually detect aggregated neurofibrillary tangles in the brain of patients with Alzheimer's,Tauvid
ZEPOSIA,ozanimod,"March 25, 2020",Treatment of multiple sclerosis,Zeposia
ISTURISA,osilodrostat,"March 6, 2020",Treatment of Cushing's disease,Isturisa
SARCLISA,isatuximab-irfc,"March 2, 2020 ",Treatment of multiple myeloma,Sarclisa  
NURTEC ODT,rimegepant,"February 27, 2020",Treatment of acute migraine,Nurtec Odt
BARHEMSYS,amisulpride,"February 26, 2020",Treatment of post-operative nausea and vomiting,Barhemsys
NEXLETOL,bempedoic acid,"February 21, 2020",Treatment of high LDL cholesterol,Nexletol
VYEPTI,eptinezumab-jjmr,"February 21, 2020",Treatment of migraines,Vyepti
PIZENSY,lactitol,"February 12, 2020",Treatment of a type of constipation called chronic idiopathic constipation (CIC),Pizensy
TAZVERIK,tazemetostat,"January 23, 2020",Treatment of advanced epithelioid sarcoma,Tazverik
TEPEZZA,teprotumumab-trbw,"January 21, 2020",Treatment of thyroid eye disease.,Tepezza
AYVAKIT,avapritinib,"January 9, 2020",Treatment of adults with certain gastrointestinal stromal tumors,Ayvakit
UBRELVY,ubrogepant,"December 23, 2019",Treatment of migraine with or without aura,Ubrelvy
CAPLYTA,lumateperone,"December 20, 2019",Treatment of schizophrenia in adults.,Caplyta
DAYVIGO,lemborexant,"December 20, 2019",Treatment of adults with insomnia.,Dayvigo
ENHERTU,fam-trastuzumab deruxtecan-nxki,"December 20, 2019",Metastatic HER2-positive breast cancer in adults,Enhertu
TISSUEBLUE,Brilliant Blue G Ophthalmic Solution,"December 20, 2019",Drug used to stain the internal limiting membrane (ILM),Tissueblue
PADCEV,enfortumab vedotin-ejfv,"December 13, 2019",For the treatment of a type of bladder and urinary tract cancer called urothelial carcinoma.,Padcev
VYONDYS 53,golodirsen,"December 12, 2019",For the treatment of a particular type of Duchenne muscular dystrophy (DMD),Vyondys 53
OXBRYTA,voxelotor,"November 25, 2019",Treatment of sickle cell disease.,Oxbryta
XCOPRI,cenobamate,"November 21, 2019",Treatment of partial-onset seizures in adult patients,Xcopri
XDEMVY,lotilaner ophthalmic solution,"July 24, 2023","To treat Demodex blepharitis, a type of eyelid infection. ",xdemvy
GIVLAARI,givosiran,"November 20, 2019",For the treatment of adults with acute hepatic porphyria (AHP).​,Givlaari
ADAKVEO,crizanlizumab-tmca,"November 15, 2019",Treatment of vasooclusive crises in patients with sickle cell disease.,Adakveo
BRUKINSA ,zanubrutinib,"November 14, 2019  ",Treatment of adults with mantle cell lymphoma,Brukinsa 
REBLOZYL,luspatercept-aamt,"November 8, 2019",For the treatment of anemia in adult patients with beta thalassemia,Reblozyl
EXEM FOAM,air polymer-Type A,"November 7, 2019",Detection of fallopian tubes patency (openness) in women with infertility,Exem Foam
TRIKAFTA,elexacaftor/tezacaftor/ivacaftor; ivacaftor,"October 21, 2019 ",Treatment of patients 12 years of age and older with the most common gene mutation that causes cystic fibrosi.,Trikafta
REYVOW,lasmiditan,"October 11, 2019","Treatment of acute migraine with or without aura, in adults",Reyvow
FLUORODOPA F 18, ,"October 10, 2019",Visual detection of certain nerve cells in adult patients with suspected Parkinsonian Syndromes (PS).,Fluorodopa f 18
SCENESSE,afamelanotide,"October 08, 2019",Increasing pain-free light exposure in adult patients with a history of phototoxic reactions (damage to skin) from erythropoietic protoporphyria,Scenesse  
BEOVU,brolucizumab-dbll,"October 7, 2019",Treatment of wet age-related macular degeneration,Beovu
AKLIEF,trifarotene,"October 4, 2019",For the topical treatment of acne vulgaris in patients 9 years of age and older,Aklief
IBSRELA,tenapanor,"September 12, 2019",Irritable bowel syndrome with constipation,Ibsrela
NOURIANZ,istradefylline  ,"August 27, 2019",Treatment of “off episodes” in patients with Parkinson’s disease,Nourianz
Ga-68-DOTATOC, ,"August 21, 2019",Detection of of tumors called somatostatin receptor positive neuro-endocrine tumors (NETs),Ga-68-dotatoc
XENLETA,lefamulin,"August 19, 2019",Treatment of community-acquired bacterial pneumonia (CABP),Xenleta
INREBIC,fedratinib,"August 16, 2019",Treatment of myelofibrosis,Inrebic
IQIRVO,elafibranor,"June 10, 2024",To treat primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults who have an inadequate response to UDCA or as monotherapy in patients unable to tolerate UDCA,iqirvo
RINVOQ,upadacitinib,"August 16, 2019",Treatment for rheumatoid arthritis,Rinvoq
ROZLYTREK,entrectinib,"August 15, 2019",Treatment of non-small cell lung cancer,Rozlytrek
ROZLYTREK,entrectinib,"August 15, 2019",Treatment of certain types of solid tumors ,Rozlytrek
PRETOMANID, ,"August 14, 2019",​Treatment of lung tuberculosis in limited population,Pretomanid
WAKIX,pitolisant,"August 14, 2019",Treatment of excessive sleepiness due to narcolepsy.,Wakix
TURALIO,pexidartinib,"August 2, 2019",Treatment of tenosynovial giant cell tumor,Turalio
NUBEQA,darolutamide ,"July 30, 2019 ",Treatment of prostate cancer ,Nubeqa 
ACCRUFER,ferric maltol,"July 25, 2019",Treatment of low iron stores,Accrufer
RECARBRIO,"imipenem, cilastatin, and relebactam","July 16, 2019",Treatment of complicated urinary tract infection,Recarbrio
XPOVIO,selinexor,"July 3, 2019",Treatment of multiple myeloma,Xpovio
VYLEESI,bremelanotide injection,"June 21, 2019",Treatment of women with hypoactive sexual desire disorder,Vyleesi
POLIVY,polatuzumab vedotin-piiq,"June 10, 2019",Treatment of adults with diffuse large B-cell lymphoma,Polivy
PIQRAY,alpelisib,"May 24, 2019",Treatment of advanced breast cancer,Piqray
VYNDAQEL / VYNDAMAX,VYNDAQEL(tafamidis meglumine)/ VYNDAMAX (tafamidis),"May 03, 2019",​Treatment of the cardiomyopathy caused by transthyretin‑mediated amyloidosis (ATTR-CM),Vyndaqel
SKYRIZI,risankizumab-rzaa,"April 23, 2019",Treatment of moderate to severe plaque psoriasis,Skyrizi
BALVERSA,erdafitinib,"April 12, 2019",For the treatment of urothelial carcinoma (a type of bladder and urinary tract cancer),Balversa
EVENITY,romosozumab-aqqg,"April 9, 2019 ",For the treatment of osteoporosis in women after menopause,Evenity 
MAYZENT,siponimod,"March 26, 2019",For treatment of adults with relapsing forms of multiple sclerosis,Mayzent
ZULRESSO,brexanolone,"March 19, 2019",Treatment of postpartum depression,Zulresso
EGATEN,triclabendazole,"February 13, 2019",Treatment of fasciolasis,Egaten
CABLIVI ,caplacizumab-yhdp;,"February 06, 2019  ",Treatment of adults with an episode of acquired thrombotic thrombocytopenic purpura (aTTP),Cablivi 
JEUVEAU,efinaconazolebotulinum toxin- type A,"February 1, 2019",Temporary improvement of the appearance of glabellar lines (wrinkles between the eyebrows).,Jeuveau
ELZONRIS,tagraxofusp-erzx,"December 21, 2018",Treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN,Elzonris
ULTOMIRIS,ravulizumab-cwvz,"December 21, 2018",Treatment of paroxysmal nocturnal hemoglobinuria (PNH),Ultomiris
ASPARLAS,calaspargase pegol-mknl,"December 20, 2018",Treatment of acute lymphoblastic leukemia (ALL),Asparlas
MOTEGRITY,prucalopride,"December 14, 2018",​Treatment of chronic idiopathic constipation (CIC) in adults.,Motegrity
FIRDAPSE,amifampridine,"November 28, 2018",Treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.,Firdapse
XOSPATA,gilteritinib,"November 28, 2018",Treatment of acute myeloid leukemia (AML) with a FLT3 mutation,Xospata
VITRAKVI,larotrectinib,"November 26, 2018",Treatment of tumors with specific biomarker,Vitrakvi
XOFLUZA,baloxavir marboxil,"November 24, 2018",Treatment of the flu (influenza) in people 12 years of age and older,Xofluza
OXLUMO,lumasiran,"November 23, 2018",Lowering the level of urine oxalate in children and adults with primary hyperoxaluria type 1 (PH1).,Oxlumo
DAURISMO,glasdegib,"November 21, 2018",Treatment of adults with newly-diagnosed acute myeloid leukemia (AML).,Daurismo
GAMIFANT,emapalumab-lzsg,"November 20, 2018",Treatment of patients with primary hemophagocytic lymphohistiocytosis,Gamifant
AEMCOLO,rifamycin,"November 16, 2018",Treatment of traveler's diarrhea in adults,Aemcolo
FETROJA,cefiderocol,"November 14, 2018",For the treatment of a complicated urinary tract infection.,Fetroja
YUPELRI,revefenacin,"November 9, 2018",Maintenance treatment of adults with a lung disease called COPD,Yupelri
LORBRENA,lorlatinib,"November 2, 2018",Treatment of specific type of lung cancer,Lorbrena
TALZENNA,talazoparib,"October 16, 2018",Treatment of adults with a specific form of breast cancer,Talzenna
REVCOVI,evolocumab,"October 5, 2018",Treatment of adenosine deaminase severe combined immune deficiency.,Revcovi
TEGSEDI,inotersen,"October 5, 2018",Treatment of nerve damage in adult patients with hereditary transthyretin-mediated amyloidosis,Tegsedi
NUZYRA,omadacycline,"October 2, 2018",Treatment of community-acquired bacterial pneumonia (CABP),Nuzyra
SEYSARA,sarecycline,"October 1, 2018",For the treatment of certain types of acne vulgaris in patients 9 years and older,Seysara
EMGALITY,galcanezumab-gnim,"September 27, 2018",Preventive treatment of migraine in adults,Emgality
VIZIMPRO,dacomitinib,"September 27, 2018",Treatment of advanced non-small cell lung cancer,Vizimpro
VONJO,pacritinib,"February 28, 2022","To treat adult patients with a rare type of bone marrow disorder called myelofibrosis with platelet counts below 50,000/µL.",VONJO
LIBTAYO,cemiplimab-rwlc,"September 25, 2018",Treatment of advanced skin cancer (squamous cell carcinoma),Libtayo
COPIKTRA,duvelisib,"September 24, 2018","Treatment of chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular lymphoma (FL)",Copiktra
AJOVY,fremanezumab-vfrm,"September 14, 2018",Preventive treatment of migraine in adults,Ajovy
LUMOXITI,moxetumomab pasudotox-tdfk,"September 13, 2018",Treatment of hairy cell leukemia in adults,Lumoxiti
PIFELTRO,doravirine,"August 30, 2018",Treatment of HIV-1 infection in adults,Pifeltro
XERAVA,eravacycline,"August 27, 2018",Complicated intra-abdominal infections caused by bacteria in patients 18 years and older,Xerava
TAKHZYRO,lanadelumab-flyo,"August 23, 2018",Prevent attacks of hereditary angioedema in people 12 years and older,Takhzyro
OXERVATE,cenegermin-bkbj,"August 22, 2018",Treatment of neurotrophic keratitis ,Oxervate
DIACOMIT,stiripentol,"August 20, 2018",Treatment of seizures in patients with Dravet syndrome,Diacomit
ANKTIVA,nogapendekin alfa inbakicept-pmnl,"April 22, 2024","To treat a subtype of non-muscle invasive bladder cancer (NMIBC), called carcinoma in situ (CIS)",Anktivia
ANNOVERA,segesterone acetate and ethinyl estradiol vaginal system,"August 10, 2018",Pregnancy prevention in women,Annovera
GALAFOLD,migalastat hydrochloride,"August 10, 2018",Treatment of Fabry disease in adults,Galafold
ONPATTRO,patisiran,"August 10, 2018",Treatment of nerve damage in adult patients with hereditary tranthyretin-mediated amyloidosis,Onpattro
POTELIGEO,mogamulizumab-kpkc,"August 8, 2018",Treatment of  adults with mycosis fungoides or Sézary syndrome,Poteligeo
MULPLETA,lusutrombopag,"July 31, 2018",Treatment of adults with low platelet count,Mulpleta
OMEGAVEN,fish oil triglycerides,"July 27, 2018",Treatment of Parenteral nutrition-associated cholestasis (PNAC),Omegaven
ORILISSA,elagolix,"July 23, 2018",Treatment of moderate to severe pain associated with endometriosis,Orilissa
KRINTAFEL,tafenoquine,"July 20, 2018","Prevention of malaria relapse caused by the parasite, Plasmodium vivax",Krintafel
TIBSOVO,ivosidenib,"July 20, 2018",Treatment of adults with acute myeloid leukemia (AML) that have a mutation in a gene called IDH1 and whose disease has come back or has not improved after previous treatment(s),Tibsovo
TPOXX,tecovirimat,"July 13, 2018",Treatment of smallpox disease,Tpoxx
BRAFTOVI,encorafenib,"June 27, 2018",Treatment of  melanoma (a type of skin cancer)  when used with another drug binimetinib  ,Bractovi
MEKTOVI,binimetinib,"June 27, 2018",Treatment of  melanoma (a type of skin cancer)  when used with another drug encorafenib.,Mektovi
EPIDIOLEX,cannabidiol,"June 25, 2018",Treatment of seizures in two rare and severe forms of epilepsy.,Epidiolex
ZEMDRI,plazomicin,"June 25, 2018",Treatment of adults who have a complicated urinary tract infection,Zemdri
MOXIDECTIN,moxidectin,"June 13, 2018",Treatment of onchocerciasis in patients 12 years of age and older,Moxidectin
OLUMIANT,baricitinib,"May 31, 2018",Treatment of adult patients with rheumatoid arthritis (RA) whose disease was not well controlled using RA medications called Tumor Necrosis Factor (TNF) antagonists,Olumiant
PALYNZIG,pegvaliase-pqpz,"May 24, 2018",Lowering the blood levels of phenylalanine in adults with phenylketonuria (PKU),Palynziq
DOPTELET,avatrombopag,"May 21, 2018",Treatment of adults with low platelet count,Doptelet
LOKELMA,sodium zirconium cyclosilicate,"May 18, 2018",Treatment of hyperkalemia in adults,Lokelma
AIMOVIG,erenumab-aooe,"May 17, 2018",Preventive treatment of migraine in adults,Aimovig
LUCEMYRA,lofexidine hydrochloride,"May 16, 2018",For the treatment of symptoms associated with opioid withdrawal during abrupt opioid discontinuation,Lucemyra
ONGENTYS,opicapone,"April 24,2018",Treatment of “off episodes” in patients with Parkinson’s disease,Ongentys
AKYNZEO,fosnetupitant and palonosetron,"April 19, 2018",Prevention of the nausea and vomiting that happens right away or later in adults receiving certain anticancer medicines (chemotherapy),Akynzeo
CRYSVITA,burosamab-twza,"April 17, 2018",For the treatment of X-linked hypophosphatemia,Crysvita
TAVALISSE,fostamatinib disodium hexahydrate,"April 17, 2018",Treatment of  adults with low platelet count due to chronic immune thrombocytopenia (ITP),Tavalisse
ILUMYA,tildrakizumab-asmn,"March 20, 2018",For the treatment of moderate to severe plaque psoriasis,Ilumya
SUNOSI,solriamfetol,"March 20, 2018",To improve wakefullness in adults with narcolepsy or obstructive sleep apnea (OSA),Sunosi
TROGARZO,ibalizumab-uiyk,"March 6, 2018",Treatment of human immunodeficiency virus 1 (HIV-1) infection in adults,Trogarzo
ERLEADA,apalutamide,"February 14, 2018",Treatment of prostate cancer that has not spread to other parts of the body (non-metastatic),Erleada
SYMDEKO,tezacaftor/ivacaftor,"February 12, 2018",For the treatment of cystic fibrosis,Symdeko
BIKTARVY,bictegravir/emtricitabine/tenofovir alafenamide,"February 7, 2018",Treatment of human immunodeficiency virus 1 (HIV-1) infection in adults.,Biktarvy
LUTATHERA,lutetium 177 dotate,"January 26, 2018",For the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs),Lutathera
GIAPREZA,angiotensin II,"December 21, 2017",Used to increase dangerously low blood pressure in adults with certain types of shock.,Giapreza
MACRILEN,macimorelin acetate ,"December 20, 2017 ",Diagnosis of growth hormone deficiency in adults ,Macrilen
STEGLATRO,ertugliflozin,"December 19, 2017",Improvement of blood sugar control in adults with type 2 diabetes when used in addition to diet and exercise.,Steglatro
RHOPRESSA,netarsudil,"December 18, 2017","Reducing elevated intraocular pressure, when the pressure inside the eye is too high",Rhopressa
XEPI,ozenoxacin,"December 11,2017",Treatment of impetigo due to certain bacteria,Xepi
OZEMPIC ,semaglutide ,"December 5, 2017 ",Improvement of blood sugar control in adults with type 2 diabetes mellitus (DM) when used in addition to diet and exercise. ,Ozempic 
HEMLIBRA,emicizumab,"November 16, 2017",Prevent ion or reduction of bleeding episodes in adults and children with hemophilia A.,Hemlibra
MEPSEVII,vestronidase alfa-vjbk,"November 15, 2017","Treatment of Mucopolysaccharidosis VII (MPS, VII, Sly syndrome)",Mepsevii
FASENRA,benralizumab,"November 14, 2017",Treatment of a specific type of severe asthma (called eosinophilic phenotype asthma),Fasenra
PREVYMIS,letermovir,"November 8, 2017",Prevention of cytomegalovirus (CMV) infection and disease in adults,Prevymis
VYZULTA,latanoprostene bunod,"November 2, 2017 ",Reducing elevated intraocular pressure (IOP),Vyzulta
CALQUENCE,acalabrutinib,"October 31, 2017",Treatment of mantle cell lymphoma (MCL),Calquence 
VERZENIO,abemaciclib,"September 28, 2017",Treatment of specific forms of breast cancer,Verzenio
SOLOSEC,secnidazole,"September 15, 2017",Used to treat adult women with vaginal infections caused by bacteria known as bacterial vaginosis,Solosec
ALIQOPA,copanlisib,"September 14, 2017",Treatment of  adults with follicular lymphoma whose disease has come back after at least two previous treatments.,Aliqopa
BENZNIDAZOLE,Benznidazole,"August 29, 2017",Treatment of Chagas disease in children 2 to 12 years of age.,Benznidazole
VABOMERE,meropenem and vaborbactam,"August 29, 2017",Treatment of adults who have a complicated urinary tract infection (abbreviated as cUTI),Vabomere
BESPONSA,inotuzumab ozogamicin,"August 17, 2017",Treatment of  adults with B-cell acute lymphoblastic leukemia (ALL).,Besponsa
MAVYRET,glecaprevir and pibrentasvir,"August 3, 2017","Treatment of adults who have a specific type of hepatitis C virus (HCV) infection, called chronic hepatitis C virus genotypes 1, 2, 3, 4, 5 or 6 infection",Mavyret
IDHIFA,enasidenib,"August 1, 2017",Treatment of adults with acute myeloid leukemia (AML) that have a mutation in a gene called IDH2 and whose disease has come back or has not improved after previous treatment(s).,Idhifa
VOSEVI,"sofosbuvir,velpatasvir and voxilaprevir","July 18, 2017","Treatment of adults who have a specific type of hepatitis C virus (HCV) infection, called chronic hepatitis C virus genotypes 1, 2, 3, 4, 5 or 6 infection ",Vosevi
NERLYNX,neratinib,"July 17, 2017",Treatment of an early stage HER2 -positive breast cancer.,Nerlynx
TREMFYA,guselkumab,"July 13, 2017", treatment of moderate to severe plaque psoriasis in adults,Tremfya
BEVYXXA,betrixaban,"June 23, 2017",Prevention of venous thromboembolism (VTE),Bevyxxa
BAXDELA,delafloxacin,"June 19, 2017",Treatment of adult patients with bacterial skin infections.,Baxdela
KEVZARA,sarilumab,"May 22, 2017",Treatment  of adult patients with moderately to severely active rheumatoid arthritis (RA),Kevzara
RADICAVA,edaravone,"May 5, 2017",Treatment of Amyotrophic Lateral Sclerosis (ALS),Radicava
IMCIVREE,setmelanotide,"May 1, 2017",Treatment of obesity in patients 6 years and older with rare disorder,Imcivree
IMFINZI,durvalumab,"May 1, 2017",Treatment of a type of bladder and urinary tract cancer called urothelial carcinoma.,Imfinzi
ALUNBRIG,brigatinib,"April 28, 2017",Treatment of a type of lung cancer called non-small cell lung cancer (NSCLC) that is advanced (metastatic).,Alunbrig
RYDAPT,midostaurin,"April 28, 2017","Treatment of adults with acute myeloid leukemia (AML) that has a mutation in a gene called FLT3, in combination with chemotherapy",Rydapt 
RYDAPT,midostaurin,"April 28, 2017",Treatment of adults with advanced systemic mastocytosis (SM),Rydapt
TYMLOS,abaloparatide,"April 28, 2017",Treatment of postmenopausal women with osteoporosis who are at high risk for bone fracture,Tymlos
TZIELD,teplizumab-mzwv,"November 17, 2022",Used to delay the onset of type 1 diabetes in children and adults who are at high risk for type 1 diabetes,Tzield
BRINEURA,cerliponase alfa,"April 27, 2017",Slowing loss of walking ability (ambulation) in symptomatic patients with a specific form of Batten disease.,Brineura
INGREZZA,valbenazine,"April 11, 2017",Treatment of tardive dyskinesia,Ingrezza
AUSTEDO,deutetrabenazine,"April 3, 2017",Treatment of chorea in patients with Huntington’s disease.,Austedo
DUPIXENT,dupilumab,"March 28, 2017",Treatment of moderate to severe atopic dermatitis in adults,Dupixent
OCREVUS,ocrelizumab,"March 28, 2017",Treatment of patients with two types of multiple sclerosis,Ocrevus
ZEJULA,niraparib,"March 27, 2017","Treatment of adult patients with recurrent ovarian cancer, fallopian tube cancer, or primary peritoneal cancer",Zejula 
BAVENCIO,avelumab,"March 23, 2017",Treatment of Merkel cell carcinoma,Bavencio
SYMPROIC,naldemedine,"March 23, 2017",Treatment for adults with constipation caused by prescription pain drugs called opioids,Symproic
XADAGO,safinamide,"March 21, 2017",Treatment of “off episodes” in patients with Parkinson’s disease,Xadago
KISQALI,ribociclib,"March 13, 2017",Treatment of a specific form of advanced breast cancer,Kisqali
KISUNLA,donanemab-azbt,"July 2, 2024",To treat people with Alzheimer’s disease,Kisunla
XERMELO,telotristat ethyl,"February 28, 2017",Treatment of diarrhea in adult patients with carcinoid syndrome,Xermelo
SILIQ,brodalumab,"February 15, 2017",SILIQ is used for treatment of moderate to severe plaque psoriasis in adults,Siliq
EMFLAZA,deflazacort,"February 9, 2017",Treatment of Duchenne muscular dystrophy (DMD) in patients 5 years of age and older,Emflaza
PARSABIV,etelcalcetide,"February 7, 2017",Treat high levels of parathyroid hormone (PTH),Parsabiv
TRULANCE,plecanatide,"January 19, 2017",Treatment of chronic idiopathic constipation in adults,Trulance
SPINRAZA,nusinersen,"December 23, 2016",Treatment of spinal muscular atrophy,Spinraza
RUBRACA,rucaparib,"December 19, 2016",Treatment of women with certain type of advanced ovarian cancer,Rubraca
EUCRISA ,crisaborole ,"December 14, 2016 ",Treatment of mild to moderate atopic dermatitis in patients 2 age years of age and older ,Eucrisa 
ZINPLAVA,bezlotoxumab,"October 21, 2016",Decreasing the risk of Clostridium difficile infection recurrence,Zinplava
LARTRUVO,olaratumab,"October 19, 2016",Treatment of soft tissue sarcoma,Lartruvo
EXONDYS 51,eteplirsen,"September 19, 2016 ",Treatment of particular type of Duchenne muscular dystrophy ,Exondys 51
FABHLATA,iptacopan,"December 5, 2023",Treatment of adults with paroxysmal nocturnal hemoglobinuria (PNH),Fabhlata
ADLYXIN,lixisenatide,"July 27, 2016",Improvement of blood sugar control in adults with diabetes mellitus (DM) type 2 when used in addition to diet and exercise,Adlyxin
XIIDRA,lifitegrast,"July 11, 2016",Treatment of the signs and symptoms of dry eye disease.,Xiidra
EPCLUSA,sofosbuvir and velpatasvir,"June 28, 2016","Treatment of chronic Hepatitis C virus genotypes 1, 2, 3, 4, 5 or 6 infection.",Epclusa
NETSPOT,kit for the preparation of gallium Ga 68 dotatate injection,"June 1, 2016",Detection of a specific type of tumors called somatostatin receptor positive neuro-endocrine tumors (NETs),Netspot
AXUMIN,fluciclovine F 18,"May 27, 2016",Detection of prostate cancer recurrence,Axumin
OCALIVA,obeticholic acid,"May 27, 2016",Treatment of primary biliary cholangitis in adults,Ocaliva
ZINBRYTA,daclizumab,"May 27, 2016",Treatment of relapsing forms of multiple sclerosis (MS),Zinbryta
TECENTRIQ,atezolizumab,"May 18, 2016",Treatment of a type of bladder cancer called urothelial carcinoma,Tecentriq
NUPLAZID,pimavanserin,"April 29, 2016",Treatment of hallucinations and delusions in patients with Parkinson’s disease,Nuplazid
VENCLEXTA,venetoclax,"April 11, 2016",Treatment of chronic lymphocytic leukemia (CLL),Venclexta
DEFITELIO,defibrotide sodium,"March 30, 2016",Treatment of hepatic veno-occlusive disease (VOD),Defitelio
CINQUAIR ,reslizumab,"March 23, 2016",Treatment of a specific type of severe asthma (called eosinophilic phenotype asthma),Cinquair
TALTZ,ixekizumab,"March 22, 2016",Treatment of moderate to severe plaque psoriasis in adults,Taltz
TALVEY,talquetamab-tgvs,"August 10, 2023",To treat a form of blood cancer called multiple myeloma,Talvey
ANTHIM,obiltoxaximab,"March 18, 2016",Treatment of inhalational anthrax,Anthim
BRIVIACT ,brivaracetam ,"February 18, 2016  ",Treatment of partial-onset seizures ,Briviact 
ZEPATIER,elbasvir and grazoprevir,"January 28, 2016",Treatment of chronic Hepatis C genotypes 1 or 4 infection,Zepatier
ZURAMPIC,lesinurad,"December 22, 2015",Lowering uric acid levels in the blood of adult patients with gout,Zurampic 
UPTRAVI,selexipag,"December 21, 2015",Treatment of adults with pulmonary artery hypertension,Uptravi
BRIDION ,sugammadex ,"December 15, 2015  ",Reversal of the effects of certain neuromuscular blocking agents ,Bridion 
ALECENSA,alectinib,"December 11, 2015",Treatment of metastatic non-small cell lung cancer,Alecensa
VISTOGARD,uridine triacetate,"December 11, 2015",Emergency treatment of an overdose with fluorouracil or capecitabine,Vistogard
KANUMA,sebelipase alfa,"December 8, 2015",Treatment of Lysosomal Acid Lipase (LAL) deficiency,Kanuma
EMPLICITI,elotuzumab,"November 30, 2015",Treatment of multiple myeloma,Empliciti
PORTRAZZA,necitumumab,"November 24, 2015",Treatment of metastatic squamous non-small cell lung cancer,Portrazza
NINLARO,ixazomib ,"November 20, 2015 ",Treatment of multiple myeloma ,Ninlaro 
DARZALEX,daratumumab,"November 16, 2015",Treatment of multiple myeloma,DarzalexExternal Link Disclaimer
TAGRISSO,osimertinib ,"November 13, 2015",Treatment of patients with advanced non-small cell lung cancer (NSCLC)  ,Tagrisso 
COTELLIC,(cobimetinib),"November 10, 2015",Part of combination treatment melanoma,Cotellic
GENVOYA,"elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide","November 5, 2015",Complete regimen for the treatment of HIV-1 in adults and children 12 years of age and older.,Genvoya
NUCALA,mepolizumab,"November 4, 2015",Treatment of a specific type of severe asthma (called eosinophilic phenotype asthma),Nucala
STRENSIQ,asfotase alfa ,"October 23, 2015 ","Treatment of perinatal, infantile and juvenile-onset hypophosphatasia (HPP) ",Strensiq 
YONDELIS ,trabectedin ,"October 23, 2015 ",Treatment of certain types of advances tissue sarcoma  ,Yondelis 
VELTASSA,patiromer,"October 21, 2015",Treatment of hyperkalemia,Veltassa
PRAXBIND,idarucizumab,"October 16, 2015",Reversal of the anticoagulant effects of Pradaxa during emergency situations or when there is a need to reverse its blood-thinning effects,Praxbindpfolda
ARISTADA,aripiprazole laurixil,"October 5, 2015",Treatment of schizophrenia,Aristada
RYZODEG,insulin degludec and insulin aspart injection,"September 26, 2015",Improves blood sugar control in adults with diabetes mellitus (DM),Ryzodeg
TRESIBA,insulin degludec injection ,"September 25, 2015 ",Improve glucose control in adults with diabetes mellitus ,Tresiba 
LONSURF,trifluridine and tipiracil,"September 22, 2015",Treatment of advanced colorectal cancer,Lonsurf
VRAYLAR,cariprazine,"September 17, 2015",Treatment of bipolar disorder,Vraylar
VRAYLAR,cariprazine,"September 17, 2015",Treatment of schizophrenia,Vraylar
XURIDEN,uridine triacetate,"September 4, 2015",Treatment of patients with hereditary orotic aciduria,Xuriden
VARUBI,rolapitant,"September 1, 2015",Prevent delayed phase chemotherapy-induced nausea and vomiting,Varubi
REPATHA,evolocumab,"August 27, 2015",Treatment of certain patients with high cholesterol,Repatha
ADDYI,flibanserin,"August 18, 2015","Treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women",Addyi
DAKLINZA,daclatasvir,"July 24, 2015",Treatment of chronic Hepatitis C genotype 3 infection,DaklinzaExternal Link Disclaimer
ODOMZO,sonidegib,"July 24, 2015",Treatment of locally advanced basal cell carcinoma ,Odomzo
PRALUENT ,alirocumab,"July 24, 2015",Treatment of certain patients with high cholesterol ,Praluent
REXULTI,brexpiprazole,"July 10, 2015",Treatment of major depressive disorder,Rexulti 
ENTRESTO,sacubitril/valsartan,"July 7, 2015",Treatment of heart failure,Entresto
ORKAMBI,lumacaftor/ivacaftor,"July 2, 2015",Treatment of cystic fibrosis,Orkambi
KENGREAL,cangrelor,"June 22, 2015",Prevention of coronary artery blood clot formation in patients undergoing PCI,Kengreal
VIBERZI,eluxadoline,"May 27, 2015",Treatment of irritable bowel syndrome with diarrhea,Viberzi
STIOLTO RESPIMAT,tiotropium bromide and olodaterol,"May 21, 2015",Long-term treatment of COPD,Stiolto Respimat
KYBELLA,deoxycholic acid,"April 29, 2015",Treatment for double chin,Kybella
CORLANOR ,ivabradine,"April 15, 2015",Reduce hospitalization from worsening heart failure.,Corlanor
CHOLBAM ,cholic acid,"March 17, 2015",Treatment of bile acid synthesis disorders due to single enzyme defects ,Cholbam 
CHOLBAM ,cholic acid,"March 17, 2015","Treatment of peroxisomal disorders, including Zellweger spectrum disorders ",Cholbam
UNITUXIN ,dinutuximab,"March 10, 2015",Treatment of children with high-risk neuroblastoma,Unituxin
CRESEMBA,isavuconazonium sulfate,"March 6, 2015",Treatment of invasive aspergillosis,Cresemba
CRESEMBA,isavuconazonium sulfate,"March 6, 2015",Treatment of invasive mucormycosis,Cresemba
AVYCAZ,ceftazidime-avibactam,"February 25, 2015",Treatment of complicated intra-abdominal infection (abbreviated as cIAI) ,Avycaz
AVYCAZ,ceftazidime-avibactam,"February 25, 2015",Treatment of complicated urinary tract infection (abbreviated as cUTI),Avycaz
FARYDAK,panobinostat,"February 23, 2015",Treatment of multiple myeloma,Farydak
LENVIMA,lenvatinib,"February 13, 2015","Treatment of progressive, differentiated thyroid cancer (DTC) that can no longer be treated with radioactive iodine ",Lenvima
IBRANCE,palbociclib,"February 3, 2015","Treatment of a specific form of advanced breast cancer called ER-positive, HER2-negative (ER+/HER-) breast cancer in women who have gone through menopause (post-menopausal)",Ibrance
NATPARA,parathyroid hormone,"January 23, 2015",Control of hypocalcemia along with calcium and vitamin D in adults with hypoparathyroidism,Natpara
COSENTYX,secukinumab,"January 21, 2015",Treatment of moderate to severe plaque psoriasis in adults who do not respond well to medication applied directly to the skin,Cosentyx
SAVAYSA,edoxaban,"January 8, 2015 ",Prevention of stroke in patients with atrial fibrillation,Savaysa  
SIVEXTRO,tedizolid,"June 20, 2014",Treatment of serious bacterial skin infections known as acute bacterial skin and skin structure infections,Sivextro
JUBLIA,efinaconazole,"June 6, 2014",Treatment of fungal infection of the toenails due to two common forms of fungi,Jublia
DALVANCE,dalbavancin hydrochloride,"May 23, 2014",Treatment of serious bacterial skin infections,Dalvance
ENTYVIO,vedolizumab,"May 20, 2014",Treatment of Crohn’s Disease,Entyvio
ENTYVIO,vedolizumab,"May 20, 2014",Treatment of Ulcerative Colitis,Entyvio
ZONTIVITY,vorapaxar,"May 8, 2014",Reduction of heart attacks and stroke in high-risk patients,Zontivity